| Debiopharm Research & Manufacturing SA - Pamorelin LA 11.25 mg, poudre et solvant pour suspension injectable à libération prolongée |
| 56349 | | 03 | | Pamorelin LA 11.25 mg | | poudre et solvant pour suspension injectable à libération prolongée | | L02AE04 | | Triptorelin | | 07.09.2018 | | |
|
| Composition |
| Praeparatio cryodesiccata: triptorelinum 11.25 mg ut triptorelini embonas, poly(lactidum-co-glycolidum), mannitolum, carmellosum natricum corresp. natrium 2.3 mg, polysorbatum 80, pro vitro.
Solvens: aqua ad iniectabile 2 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | | | | | | | | | Active Agent | Dose |
|---|
| Triptoreline | 11.25 mg |
| | BAG: Active Agent | Dose |
|---|
| Triptoreline | 11.25 mg |
| | | | Inactive agents |
|---|
| Carmellose Sodium | | Mannitol | | | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 320.02 | 364.45 | A | SL | No |
|
